Pharmacy Drugs
Recent Posts
- EPIX Pharmaceuticals Announces FDA Approval Of A Physician-Sponsored IND For Fourth 6-month Open Label Extension Of PRX-03140 For Alzheimer’s Disease
- Miriam Hospital Researcher Receives More Than $12 Million To Study Weight Control
- Novel HIV Drug To Be Studied In Cell Cultures And Patients
- ISCTM Meeting Discusses Clinical And Regulatory Aspects Of Using Adaptive Designs In Clinical Trials For Central Nervous System Drug Approvals
- Evaluation Of The Cost Effectiveness Of Implantable Blood Pressure Device
Random Posts
- Depomed Completes Enrollment Of Phase 3 Clinical Program Of DM-1796 In Post-Herpetic Neuralgia
- No Change In Pharmacokinetics Of ADHD Medication VYVANSE CII When Coadministered With Prilosec
- NCPA Statement On House Democrats' Bill On Health Care Reform
- 2-Week Course Of Sleep Aid Increases CPAP Adherence In OSA Patients At 6 Months
- Panel Recommends Everolimus in Kidney Transplant
- St. Jude Medical Announces Results From STAR-AF Trial
- EPIX Pharmaceuticals Announces FDA Approval Of A Physician-Sponsored IND For Fourth 6-month Open Label Extension Of PRX-03140 For Alzheimer's Disease
- Study Aims To Induce Recovery From Ankylosing Spondylitis
- Medtronic Launches Clinical Trial To Improve Quality Of Care For Implantable Defibrillator Patients
- FDA Lays Framework for Expedited H1N1 Vaccine Approvals
Patients Say Costs Determining Factor In Their Treatment Decisions
Posted by: admin in Pharmacy Drugs on October 09th, 2009
Seventy-three percent of insured patients receiving assistance from Patient Access Network (PAN) Foundation reported that health care costs are influencing their medication and treatment decisions more this year than last. Nearly half of these said that cost is having a “very big” or “big” impact on whether they seek treatment or fill prescriptions.
The results were part of a 2009 patient survey to determine the effects of the economy, the impact of PAN assistance on patients’ lives and their satisfaction with PAN services. PAN helps insured individuals make copayments for medications for 21 specific diseases, including certain cancers and a number of chronic illnesses.
“Our patients do have health insurance; many have Medicare, and yet they still can’t meet all the out-of-pocket costs required for life-sustaining medications,” said Lyn Boocock-Taylor, chair of the PAN Board of Directors. “The needs of our patients and of the estimated 25 million underinsured people nationwide simply must be considered in the current health care reform debate.”
For a number of patients struggling to meet medical costs, timely PAN help sometimes means the difference between life and death, as a cutaneous T-cell lymphoma patient from Colorado wrote: “I was dying because I did not have the means to fight my cancer…thanks, thanks, thanks.”
For others, like a rheumatoid arthritis patient from Texas, PAN’s assistance eliminated their need to make tough financial choices, saying that: “[With PAN help] I do not have to choose my treatment over other bills that need to be paid.”
Patients receiving PAN assistance also reported a striking 28 percent increase (from 71 to 99 percent) in their ability to comply with physicians’ medication orders, because of their copayment assistance for vital medications and infusions. Failure to take prescriptions as prescribed often disrupts the medication’s helpful effects and can lead to negative consequences such as hospitalization.
Patients said that the copayment assistance reduced family financial and emotional strain, improved their overall health and ability to take medications as prescribed and sometimes sufficiently improved their health allowing their return to work or education.
“We know patients are struggling, but these survey results confirm that we are truly reaching those who need help and making a difference in their lives,” said Julie Reynes, President of PAN.
Additionally, PAN enjoys a patient satisfaction rate of 97%. Patients say that PAN’s professional case managers staffing the call center are compassionate and helpful.
PAN is a nonprofit foundation dedicated to providing copayment assistance to insured patients who otherwise lack the means to meet out-of-pocket medication costs for specific diseases. Since 2004, PAN has helped more than 60,000 patients across the United States and U.S. territories.
Source: Patient Access Network Foundation